Literature DB >> 21183223

Stress response circuitry hypoactivation related to hormonal dysfunction in women with major depression.

Laura M Holsen1, Sarah B Spaeth, Jong-Hwan Lee, Lauren A Ogden, Anne Klibanski, Susan Whitfield-Gabrieli, Jill M Goldstein.   

Abstract

BACKGROUND: Women have approximately twice the risk of major depressive disorder (MDD) than men, yet this difference remains largely unexplained. Previous MDD research suggests high rates of endocrine dysfunction, which may be related to deficits in brain activity in stress response circuitry [hypothalamus, amygdala, hippocampus, anterior cingulate cortex (ACC), orbitofrontal cortex (OFC)]. This functional magnetic resonance imaging (fMRI) study investigated the relationship between hypothalamic-pituitary-gonadal (HPG)-axis hormones and stress response circuitry dysfunction in MDD in women.
METHODS: During the late follicular/midcycle phase of the menstrual cycle, female participants (10 with extensive histories of MDD, in remission, 10 healthy controls) were scanned while viewing negative and neutral arousal pictures. Group differences in blood oxygen-level dependent (BOLD) signal changes were analyzed using SPM2. Baseline gonadal hormones included estradiol, progesterone, and testosterone.
RESULTS: fMRI results showed greater BOLD signal intensity changes in controls versus MDD in hypothalamus, amygdala, hippocampus, OFC, ACC, and subgenual ACC, findings unrelated to medication status. MDD women had a lower serum estradiol and higher serum progesterone compared to controls. Hypoactivations in hypothalamus, subgenual ACC, amygdala and OFC in MDD were associated with low estradiol and high progesterone. LIMITATIONS: Generalizability of our findings is limited by small sample size and restriction to females, although this did not affect the internal validity of the results.
CONCLUSIONS: Hypoactivation of the stress response circuitry in MDD women is associated with dysregulation of the HPG-axis. Associations between brain activity deficits and hormonal disruption in MDD may ultimately contribute to understanding sex differences in MDD.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21183223      PMCID: PMC3073153          DOI: 10.1016/j.jad.2010.11.024

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  38 in total

1.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

2.  Abnormal prefrontal and anterior cingulate activation in major depressive disorder during episodic memory encoding of sad stimuli.

Authors:  C Fahim; E Stip; A Mancini-Marie; B Mensour; J-M Leroux; G Beaudoin; P Bourgouin; M Beauregard
Journal:  Brain Cogn       Date:  2004-03       Impact factor: 2.310

3.  Mortality by cause for eight regions of the world: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-03       Impact factor: 79.321

4.  Activation in dorsolateral prefrontal cortex in response to maternal criticism and praise in recovered depressed and healthy control participants.

Authors:  Jill M Hooley; Staci A Gruber; Laurie A Scott; Jordan B Hiller; Deborah A Yurgelun-Todd
Journal:  Biol Psychiatry       Date:  2005-04-01       Impact factor: 13.382

Review 5.  Prefrontal cortical-amygdalar metabolism in major depression.

Authors:  W C Drevets
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

6.  The functional neuroanatomy of major depression: an fMRI study using an emotional activation paradigm.

Authors:  M Beauregard; J M Leroux; S Bergman; Y Arzoumanian; G Beaudoin; P Bourgouin; E Stip
Journal:  Neuroreport       Date:  1998-10-05       Impact factor: 1.837

Review 7.  Gene expression of progesterone receptor isoforms in the rat brain.

Authors:  J Kato; S Hirata; A Nozawa; N Yamada-Mouri
Journal:  Horm Behav       Date:  1994-12       Impact factor: 3.587

8.  Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls.

Authors:  W Baischer; G Koinig; B Hartmann; J Huber; G Langer
Journal:  Psychoneuroendocrinology       Date:  1995       Impact factor: 4.905

9.  Amygdalar interhemispheric functional connectivity differs between the non-depressed and depressed human brain.

Authors:  William Irwin; Michael J Anderle; Heather C Abercrombie; Stacey M Schaefer; Ned H Kalin; Richard J Davidson
Journal:  Neuroimage       Date:  2004-02       Impact factor: 6.556

10.  A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder.

Authors:  Simon Surguladze; Michael J Brammer; Paul Keedwell; Vincent Giampietro; Andrew W Young; Michael J Travis; Steven C R Williams; Mary L Phillips
Journal:  Biol Psychiatry       Date:  2005-02-01       Impact factor: 13.382

View more
  35 in total

1.  Postmenopausal hormone use impact on emotion processing circuitry.

Authors:  Tal Shafir; Tiffany Love; Alison Berent-Spillson; Carol C Persad; Heng Wang; Nancy K Reame; Kirk A Frey; Jon-Kar Zubieta; Yolanda R Smith
Journal:  Behav Brain Res       Date:  2011-09-14       Impact factor: 3.332

2.  Factors associated with antidepressant, anxiolytic, and other psychotropic medication use to treat psychiatric symptoms in the city of São Paulo, Brazil.

Authors:  Sergio L Blay; Gerda G Fillenbaum; José C Pitta; Erica T Peluso
Journal:  Int Clin Psychopharmacol       Date:  2014-05       Impact factor: 1.659

Review 3.  Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches.

Authors:  Mary L Phillips; Henry W Chase; Yvette I Sheline; Amit Etkin; Jorge R C Almeida; Thilo Deckersbach; Madhukar H Trivedi
Journal:  Am J Psychiatry       Date:  2015-02-01       Impact factor: 18.112

4.  Depressive symptoms and risk of uterine leiomyomata.

Authors:  Lauren A Wise; Se Li; Julie R Palmer; Lynn Rosenberg
Journal:  Am J Obstet Gynecol       Date:  2014-12-13       Impact factor: 8.661

Review 5.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

6.  A developmental study of the feedback-related negativity from 10-17 years: age and sex effects for reward versus non-reward.

Authors:  Michael J Crowley; Jia Wu; Rebecca E Hommer; Mikle South; Peter J Molfese; R M P Fearon; Linda C Mayes
Journal:  Dev Neuropsychol       Date:  2013       Impact factor: 2.253

7.  Sex differences, hormones, and fMRI stress response circuitry deficits in psychoses.

Authors:  Jill M Goldstein; Katie Lancaster; Julia M Longenecker; Brandon Abbs; Laura M Holsen; Sara Cherkerzian; Susan Whitfield-Gabrieli; Nicolas Makris; Ming T Tsuang; Stephen L Buka; Larry J Seidman; Anne Klibanski
Journal:  Psychiatry Res       Date:  2015-03-31       Impact factor: 3.222

8.  Striatal Hypersensitivity During Stress in Remitted Individuals with Recurrent Depression.

Authors:  Roee Admon; Laura M Holsen; Harlyn Aizley; Anne Remington; Susan Whitfield-Gabrieli; Jill M Goldstein; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2014-10-02       Impact factor: 13.382

9.  GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study.

Authors:  Kristina M Deligiannidis; Elif M Sikoglu; Scott A Shaffer; Blaise Frederick; Abby E Svenson; Andre Kopoyan; Chelsea A Kosma; Anthony J Rothschild; Constance M Moore
Journal:  J Psychiatr Res       Date:  2013-03-15       Impact factor: 4.791

10.  Volumetric parcellation methodology of the human hypothalamus in neuroimaging: normative data and sex differences.

Authors:  Nikos Makris; Dick F Swaab; Andre van der Kouwe; Brandon Abbs; Denise Boriel; Robert J Handa; Stuart Tobet; Jill M Goldstein
Journal:  Neuroimage       Date:  2012-12-14       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.